The nationwide experiment will initially include around 100,000 volunteers.
To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.
To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.
Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.
With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.
Researchers identify 72 novel genetic variants associated with breast cancer risk.
At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling.
A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.
Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.
Combined transcription and genome data from multiple tissues in hundreds of human donors reveal links between genotype and gene expression across the body.
Tissue recipients were treated as “guinea pigs,” says investigation leader.
Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.